Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 669
Selected: 0
NCT IDTitle
NCT00876343Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
NCT014518278-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT01142284Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and Safety
NCT01618448Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart Failure
NCT01228682Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical Practice
NCT04081363Open-label, Single-dose Trial to Assess the Pharmacokinetics of Centanafadine Extended-release Capsules in Pediatric Participants With Attention-deficit Hyperactivity Disorder (ADHD)
NCT00394485Tiotropium + Procaterol vs Tiotropium + Placebo in COPD Patients
NCT01182415High Dose Chemotherapy and Stem Cell Transplant for Non-Hodgkin's Lymphoma or Central Nervous System (CNS) Lymphoma
NCT01727713Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
NCT06372210A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion
NCT01349335Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
NCT03872596Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder
NCT00283179Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia
NCT05504486Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety
NCT00036127Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
NCT01043250Effects of Atypical Antipsychotics on Appetite and Eating Behavior of Schizophrenia Patients
NCT04100096A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder
NCT03620981Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT00277212A Phase IV Study of the Safety and Efficacy of Aripiprazole in Combination With Lamotrigine in the Long-Term Maintenance Treatment of Patients With Bipolar I Disorder With A Recent Manic or Mixed Episode
NCT01590901Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects
NCT03594123A 12-week Extension Trial to Evaluate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type
NCT05628103A Clinical Study That Will Evaluate How Well SEP-363856 Works and How Safe it is in People With Schizophrenia That Switch to SEP-363856 From Their Current Antipsychotic Medication
NCT00095524Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder
NCT00257972Study of Aripiprazole in Patients With Bipolar I Disorder
NCT00300846A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic Patients
NCT01122927Safety and Tolerability of Aripiprazole in Adolescents With Schizophrenia or Children and Adolescents With Bipolar I Disorder, Manic or Mixed Episode With or Without Psychotic Features.
NCT01810380Brexpiprazole in Patients With Acute Schizophrenia
NCT00234104A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)
NCT00216749Efficacy and Safety of Cilostazol for the Indication of CSPS
NCT02194933Monotherapy Brexpiprazole (OPC-34712) Trial in the Treatment of Adults With Schizophrenia With Impulsivity
NCT00041678Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
NCT05536414Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
NCT01026584Efficacy and Safety of Aripiprazole in First Episode Psychosis
NCT01141387Outcomes in MEasurement-Based Treatment
NCT05615363A Dose-ranging Trial of OPC-131461 in Cardiac Edema (Congestive Heart Failure [CHF])
NCT00791999Efficacy Confirmation Trial of CDP870 as add-on Medication to Methotrexate (MTX) in Japanese Rheumatoid Arthritis (RA)
NCT03548584A Trial to Evaluate the Safety, Efficacy, and Tolerability of Brexpiprazole in Treating Agitation Associated With Dementia of the Alzheimer's Type
NCT00511082Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma
NCT02108288Pharmacokinetic Study of OPC-1085EL Ophthalmic Solution in Healthy Male Adult Volunteers
NCT04189705A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
NCT03487783Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome
NCT01493180Exploratory Study of OPC-12759 Ophthalmic Suspension
NCT00365859Study of Aripiprazole in the Treatment of Serious Behavioral Problems in Children and Adolescents With Autistic Disorder (AD)
NCT01022424A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002]
NCT01565018Bioequivalence Study of Rotigotine Transdermal Patch With Two Different Formulations in Healthy Japanese Subjects
NCT01961882A Phase 2 Trial to Evaluate the Efficacy and Safety of OCV-501 in Elderly Patients With Acute Myeloid Leukemia
NCT01696617Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
NCT01337089Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
NCT07166783Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol
NCT02068352A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis